Professor Piotr Popik, PhD
I am an active academic scientist with an overall
research focus in behavioral psychopharmacology and behavioral and cognitive
neuroscience. I have strong interests in drug discovery and development, this
is why our lab collaborates with a number of dug companies. I am a Professor of
Medical Biology doing preclinical research at the Institute of Pharmacology,
Polish Academy of Sciences. I have a strong interest in education and teaching
of Pharmacology at the Jagiellonian University, Medical College in Kraków. I
have published over 120 peer-reviewed manuscripts, several book chapters and
one book. I have trained and supervised 3 PhD students. Happily married and
having three children.
-
Novel non-sulfonamide 5-HT6receptor partial inverse agonist in a group of imidazo[4,5-b]pyridines with cognition enhancing properties.
David Vanda, Miroslav Soural, Vittorio Canale, Séverine Chaumont-Dubel, Grzegorz Satała, Tomasz Kos, Petr Funk, Veronika Fülöpová, Barbora Lemrová, Paulina Koczurkiewicz, Elżbieta Pękala, Andrzej J Bojarski, Piotr Popik, Philippe Marin, Paweł Zajdel
European journal of medicinal chemistry, S0223-5234(17)31084-X 10.1016/j.ejmech.2017.12.053
PMID:29291439 -
Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile.
Vittorio Canale, Anna Partyka, Rafał Kurczab, Martyna Krawczyk, Tomasz Kos, Grzegorz Satała, Bartłomiej Kubica, Magdalena Jastrzębska-Więsek, Anna Wesołowska, Andrzej J Bojarski, Piotr Popik, Paweł Zajdel
Bioorganic & medicinal chemistry, S0968-0896(17)30359-0 10.1016/j.bmc.2017.03.057
PMID:28391970 -
3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats.
Agnieszka Potasiewicz, Małgorzata Hołuj, Tomasz Kos, Piotr Popik, Hugo R Arias, Agnieszka Nikiforuk
Neuropharmacology, S0028-3908(16)30450-6 10.1016/j.neuropharm.2016.10.002
PMID:27717880 -
N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties.
Paweł Zajdel, Krzysztof Marciniec, Grzegorz Satała, Vittorio Canale, Tomasz Kos, Anna Partyka, Magdalena Jastrzębska-Więsek, Anna Wesołowska, Agnieszka Basińska-Ziobroń, Jacek Wójcikowski, Władysława A Daniel, Andrzej J Bojarski, Piotr Popik
ACS medicinal chemistry letters, 10.1021/acsmedchemlett.6b00056
PMID:27326337 -
The effects of PDE10 inhibition on attentional set-shifting do not depend on the activation of dopamine D1 receptors.
Agnieszka Nikiforuk, Agnieszka Potasiewicz, Dominik Rafa, Karla Drescher, Anton Bespalov, Piotr Popik
Behavioural pharmacology, 10.1097/FBP.0000000000000201
PMID:26580130
